BOTOX has been listed on the
Pharmaceutical Benefits Scheme
for the treatment of Severe Primary
Axillary Hyperhidrosis (SAHH), a
medical condition which causes
excessive underarm sweating.
Botox is now available on the PBS
for children aged over 12 and
adults who are intolerant to Driclor,
or for whom this type of
antiperspirant does not work after
up to two hours of treatment.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Oct 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Oct 12
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.